When.com Web Search

  1. Ads

    related to: breast cancer genetic testing companies list in indiana

Search results

  1. Results From The WOW.Com Content Network
  2. Myriad Genetics - Wikipedia

    en.wikipedia.org/wiki/Myriad_Genetics

    Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States.Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease.

  3. List of genetics research organizations - Wikipedia

    en.wikipedia.org/wiki/List_of_genetics_research...

    This is a list of organizations involved in genetics research. Africa. Kenya ... Dana–Farber Cancer Institute; Whitehead Institute for Biomedical Research ...

  4. This Christmas, ask for genetic testing. It could save your life.

    www.aol.com/christmas-ask-genetic-testing-could...

    Doctors discovered a lump during her sister's mammogram back in 2008 that came back positive for breast cancer. Genetic testing revealed both had the BRCA gene – one that puts someone at higher ...

  5. Natera - Wikipedia

    en.wikipedia.org/wiki/Natera

    Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows ...

  6. GeneDx - Wikipedia

    en.wikipedia.org/wiki/GeneDx

    GeneDx settled a patent dispute with Myriad Genetics in February 2015 after GeneDx launched a BRCA mutation breast cancer genetic screening test following the US Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics, Inc. that concluded isolated gene sequences were patent ineligible. [11]

  7. Genentech - Wikipedia

    en.wikipedia.org/wiki/Genentech

    It was most publicized for its approval in advanced breast cancer treatment, but the FDA approval for breast cancer treatment was subsequently revoked in November 2011. 2004: Tarceva (erlotinib): Treatment for patients with locally advanced or metastatic non-small cell lung cancer, and pancreatic cancer.

  1. Ads

    related to: breast cancer genetic testing companies list in indiana